 | • レポートコード：GIR-105X12472 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ニラパリブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ニラパリブの種類別市場規模（100mg * 30カプセル、100mg * 60カプセル、100mg * 90カプセル）、用途別市場規模（再発性上皮性卵巣癌、卵管癌、原発性腹膜癌、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ニラパリブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：TESARO、Everest Pharmaceuticals Limited ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：100mg * 30カプセル、100mg * 60カプセル、100mg * 90カプセル ・用途別分析2016年-2026年：再発性上皮性卵巣癌、卵管癌、原発性腹膜癌、その他 ・ニラパリブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ニラパリブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ニラパリブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ニラパリブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ニラパリブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Niraparib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Niraparib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Niraparib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Niraparib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100mg*30 Capsules
100mg*60 Capsules
100mg*90 Capsules
Market segment by Application can be divided into
Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Other
The key market players for global Niraparib market are listed below:
TESARO
Everest Pharmaceuticals Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Niraparib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Niraparib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100mg*30 Capsules
1.2.3 100mg*60 Capsules
1.2.4 100mg*90 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Niraparib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Recurrent Epithelial Ovarian Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Primary Peritoneal Cancer
1.3.5 Other
1.4 Global Niraparib Market Size & Forecast
1.4.1 Global Niraparib Sales in Value (2016-2026))
1.4.2 Global Niraparib Sales in Volume (2016-2026)
1.4.3 Global Niraparib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Niraparib Production Capacity Analysis
1.5.1 Global Niraparib Total Production Capacity (2016-2026)
1.5.2 Global Niraparib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Niraparib Market Drivers
1.6.2 Niraparib Market Restraints
1.6.3 Niraparib Trends Analysis
2 Manufacturers Profiles
2.1 TESARO
2.1.1 TESARO Details
2.1.2 TESARO Major Business
2.1.3 TESARO Niraparib Product and Services
2.1.4 TESARO Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Everest Pharmaceuticals Limited
2.2.1 Everest Pharmaceuticals Limited Details
2.2.2 Everest Pharmaceuticals Limited Major Business
2.2.3 Everest Pharmaceuticals Limited Niraparib Product and Services
2.2.4 Everest Pharmaceuticals Limited Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Niraparib Sales by Manufacturer
3.1 Global Niraparib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Niraparib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Niraparib
3.4 Market Concentration Rate
3.4.1 Top 3 Niraparib Manufacturer Market Share
3.4.2 Top 6 Niraparib Manufacturer Market Share
3.5 Global Niraparib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Niraparib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Niraparib Market Size by Region
4.1.1 Global Niraparib Sales in Volume by Region (2016-2026)
4.1.2 Global Niraparib Revenue by Region (2016-2026)
4.2 North America Niraparib Revenue (2016-2026)
4.3 Europe Niraparib Revenue (2016-2026)
4.4 Asia-Pacific Niraparib Revenue (2016-2026)
4.5 South America Niraparib Revenue (2016-2026)
4.6 Middle East and Africa Niraparib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Niraparib Sales in Volume by Type (2016-2026)
5.2 Global Niraparib Revenue by Type (2016-2026)
5.3 Global Niraparib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Niraparib Sales in Volume by Application (2016-2026)
6.2 Global Niraparib Revenue by Application (2016-2026)
6.3 Global Niraparib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Niraparib Sales by Type (2016-2026)
7.2 North America Niraparib Sales by Application (2016-2026)
7.3 North America Niraparib Market Size by Country
7.3.1 North America Niraparib Sales in Volume by Country (2016-2026)
7.3.2 North America Niraparib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Niraparib Sales by Type (2016-2026)
8.2 Europe Niraparib Sales by Application (2016-2026)
8.3 Europe Niraparib Market Size by Country
8.3.1 Europe Niraparib Sales in Volume by Country (2016-2026)
8.3.2 Europe Niraparib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Niraparib Sales by Type (2016-2026)
9.2 Asia-Pacific Niraparib Sales by Application (2016-2026)
9.3 Asia-Pacific Niraparib Market Size by Region
9.3.1 Asia-Pacific Niraparib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Niraparib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Niraparib Sales by Type (2016-2026)
10.2 South America Niraparib Sales by Application (2016-2026)
10.3 South America Niraparib Market Size by Country
10.3.1 South America Niraparib Sales in Volume by Country (2016-2026)
10.3.2 South America Niraparib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Niraparib Sales by Type (2016-2026)
11.2 Middle East & Africa Niraparib Sales by Application (2016-2026)
11.3 Middle East & Africa Niraparib Market Size by Country
11.3.1 Middle East & Africa Niraparib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Niraparib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Niraparib Typical Distributors
12.3 Niraparib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Niraparib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Niraparib Revenue by Application, (USD Million), 2021-2026
Table 3. TESARO Basic Information, Manufacturing Base and Competitors
Table 4. TESARO Major Business
Table 5. TESARO Niraparib Product and Services
Table 6. TESARO Niraparib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Everest Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 8. Everest Pharmaceuticals Limited Major Business
Table 9. Everest Pharmaceuticals Limited Niraparib Product and Services
Table 10. Everest Pharmaceuticals Limited Niraparib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Niraparib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global Niraparib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Niraparib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Niraparib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Niraparib Production Site of Key Manufacturer
Table 16. Global Niraparib Sales by Region (2016-2021e) & (K Pcs)
Table 17. Global Niraparib Sales by Region (2021-2026) & (K Pcs)
Table 18. Global Niraparib Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Niraparib Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Niraparib Sales by Type (2016-2021e) & (K Pcs)
Table 21. Global Niraparib Sales by Type (2021-2026) & (K Pcs)
Table 22. Global Niraparib Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Niraparib Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Niraparib Price by Type (2016-2021e) & (USD/Pcs)
Table 25. Global Niraparib Price by Type (2021-2026) & (USD/Pcs)
Table 26. Global Niraparib Sales by Application (2016-2021e) & (K Pcs)
Table 27. Global Niraparib Sales by Application (2021-2026) & (K Pcs)
Table 28. Global Niraparib Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Niraparib Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Niraparib Price by Application (2016-2021e) & (USD/Pcs)
Table 31. Global Niraparib Price by Application (2021-2026) & (USD/Pcs)
Table 32. North America Niraparib Sales by Country (2016-2021e) & (K Pcs)
Table 33. North America Niraparib Sales by Country (2021-2026) & (K Pcs)
Table 34. North America Niraparib Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Niraparib Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Niraparib Sales by Type (2016-2021e) & (K Pcs)
Table 37. North America Niraparib Sales by Type (2021-2026) & (K Pcs)
Table 38. North America Niraparib Sales by Application (2016-2021e) & (K Pcs)
Table 39. North America Niraparib Sales by Application (2021-2026) & (K Pcs)
Table 40. Europe Niraparib Sales by Country (2016-2021e) & (K Pcs)
Table 41. Europe Niraparib Sales by Country (2021-2026) & (K Pcs)
Table 42. Europe Niraparib Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Niraparib Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Niraparib Sales by Type (2016-2021e) & (K Pcs)
Table 45. Europe Niraparib Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Niraparib Sales by Application (2016-2021e) & (K Pcs)
Table 47. Europe Niraparib Sales by Application (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Niraparib Sales by Region (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Niraparib Sales by Region (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Niraparib Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Niraparib Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Niraparib Sales by Type (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Niraparib Sales by Type (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Niraparib Sales by Application (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific Niraparib Sales by Application (2021-2026) & (K Pcs)
Table 56. South America Niraparib Sales by Country (2016-2021e) & (K Pcs)
Table 57. South America Niraparib Sales by Country (2021-2026) & (K Pcs)
Table 58. South America Niraparib Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Niraparib Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Niraparib Sales by Type (2016-2021e) & (K Pcs)
Table 61. South America Niraparib Sales by Type (2021-2026) & (K Pcs)
Table 62. South America Niraparib Sales by Application (2016-2021e) & (K Pcs)
Table 63. South America Niraparib Sales by Application (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Niraparib Sales by Country (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Niraparib Sales by Country (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Niraparib Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Niraparib Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Niraparib Sales by Type (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Niraparib Sales by Type (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Niraparib Sales by Application (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa Niraparib Sales by Application (2021-2026) & (K Pcs)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Niraparib Typical Distributors
Table 75. Niraparib Typical Customers
List of Figures
Figure 1. Niraparib Picture
Figure 2. Global Niraparib Sales Market Share by Type in 2020
Figure 3. 100mg*30 Capsules
Figure 4. 100mg*60 Capsules
Figure 5. 100mg*90 Capsules
Figure 6. Global Niraparib Sales Market Share by Application in 2020
Figure 7. Recurrent Epithelial Ovarian Cancer
Figure 8. Fallopian Tube Cancer
Figure 9. Primary Peritoneal Cancer
Figure 10. Other
Figure 11. Global Niraparib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Niraparib Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Niraparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Niraparib Sales (2016-2026) & (K Pcs)
Figure 33. Global Niraparib Production Capacity (2016-2026) & (K Pcs)
Figure 34. Global Niraparib Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Niraparib Market Drivers
Figure 36. Niraparib Market Restraints
Figure 37. Niraparib Market Trends
Figure 38. Global Niraparib Sales Market Share by Manufacturer in 2020
Figure 39. Global Niraparib Revenue Market Share by Manufacturer in 2020
Figure 40. Niraparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Niraparib Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Niraparib Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Niraparib Sales Market Share by Region (2016-2026)
Figure 44. Global Niraparib Revenue Market Share by Region (2016-2026)
Figure 45. North America Niraparib Revenue (2016-2026) & (USD Million)
Figure 46. Europe Niraparib Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Niraparib Revenue (2016-2026) & (USD Million)
Figure 48. South America Niraparib Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Niraparib Revenue (2016-2026) & (USD Million)
Figure 50. Global Niraparib Sales Market Share by Type (2016-2026)
Figure 51. Global Niraparib Revenue Market Share by Type (2016-2026)
Figure 52. Global Niraparib Price by Type (2016-2026) & (USD/Pcs)
Figure 53. Global Niraparib Sales Market Share by Application (2016-2026)
Figure 54. Global Niraparib Revenue Market Share by Application (2016-2026)
Figure 55. Global Niraparib Price by Application (2016-2026) & (USD/Pcs)
Figure 56. North America Niraparib Sales Market Share by Country (2016-2026)
Figure 57. North America Niraparib Revenue Market Share by Country (2016-2026)
Figure 58. North America Niraparib Sales Market Share by Type (2016-2026)
Figure 59. North America Niraparib Sales Market Share by Application (2016-2026)
Figure 60. Europe Niraparib Sales Market Share by Country (2016-2026)
Figure 61. Europe Niraparib Revenue Market Share by Country (2016-2026)
Figure 62. Europe Niraparib Sales Market Share by Type (2016-2026)
Figure 63. Europe Niraparib Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Niraparib Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Niraparib Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Niraparib Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Niraparib Sales Market Share by Application (2016-2026)
Figure 68. South America Niraparib Sales Market Share by Country (2016-2026)
Figure 69. South America Niraparib Revenue Market Share by Country (2016-2026)
Figure 70. South America Niraparib Sales Market Share by Type (2016-2026)
Figure 71. South America Niraparib Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Niraparib Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Niraparib Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Niraparib Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Niraparib Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
卵巣がんの遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 卵巣がんの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. Scope of the Report: This report studies the Ovarian Cancer market status and outlook of G…
- 世界の卵巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Ovarian Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 卵巣がん薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment…
- 世界のニンテダニブ市場 2021：企業別、地域別、種類・用途別 The Nintedanib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …